Cardiovascular diseases
CVDs
health problem
advanced
developing countries
world
study
investigate
protective effect
Solidago virgaurea extract
isoproterenol-induced cardiotoxicity
rats
subcutaneous
injection
isoproterenol
rats
interval
consecutive
days
increase
serum lactate dehydrogenase
creatine phosphokinase
alanine transaminase
aspartate transaminase
angiotensin-converting enzyme activities
total cholesterol
triglycerides
free serum fatty acid
cardiac tissue malondialdehyde
MDA
nitric oxide
decrease
levels
glutathione
superoxide dismutase
cardiac tissue
normal control group
Pretreatment
S. virgaurea
weeks
dose
isoproterenol
injection
alterations
Captopril
orally
inhibitor
angiotensin-converting enzyme
cardioprotective drug
positive control
study
data
study
S. virgaurea
protective effect
decreasing
MDA
level
increasing
antioxidant status
isoproterenol-treated rats
study
S. virgaurea
cardioprotective agent
